RE:Using dollar cost averaging for this stock.Buying shares that is a good move.
I look at VET opportunity in more simplistic terms. With average FCF over the last 4 Quarters of 188 million to a quarter. So in the last 4 quarter they generated 750 million dollars in FCF.
Now that they have only roughly 150 million shares for simplicity, that is close to $5 dollars a share FCF in the trailing 4 quarters. Considering VET only paid 46 cents in the last 4 quarter in dividends, that means about $4.50 a share is going to buybacks and debt reduction.
So if $4.50 has been directed toward the balance sheet over the last year, and the share price a year ago was Dec 5, 2023 $15.82.
So one might suggest that VET is a value trap, but what I am say is that the intrinsic value embedded in VET is not being recognize as the share price a year ago was $15.82 + $4.50 in FCF added to the balance sheet, plus the capex advancement bringing on Croatia, Mica production, and exploration success in Germany.
My thesis is this the stock is grossly undervalued, and shareholders should have that discussion with IR and the companies management, because of the share price under performance.
Please don't take this as management underperformance, but the question now to management is how does VET communicate to market their major economic advantage, roughly getting Europen gas pricing, and the economic advantage of gas production at the receiving end of LNG.
IMHO
MHP